Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients.
Haematologica
; 105(4): e190-e193, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31399525
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukocytes, Mononuclear
/
Lymphoma
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2020
Document type:
Article
Country of publication:
Italia